# Qurient

Source: https://onco.cc/companies/qurient/  
OnCo record `qurient` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Qurient is a South Korean biotechnology company in Seongnam that leads two cancer trials in OnCo, testing the selective CDK7 inhibitor Q901 and the Axl/Mer/CSF1R inhibitor Q702, each with pembrolizumab, in advanced solid tumours.

## Summary

Qurient is a company based in Seongnam, South Korea (Wikidata Q30253835; no website is recorded there, so none is given here). ClinicalTrials.gov classes it as an industry sponsor, with Merck Sharp & Dohme as collaborator on the pembrolizumab combinations. It leads two phase 1/2 trials recorded in OnCo: NCT05394103 (Q901, a highly selective CDK7 inhibitor, alone and with pembrolizumab in selected advanced solid tumours) and NCT05438420 (Q702, an oral Axl/Mer/CSF1R tyrosine kinase inhibitor, with pembrolizumab, recorded under cervical cancer). Both compounds are its own, the basis for the biotech type.

## Fields

- Kind: Company
- Last checked: 2026-09-22
- Also known as: Qurient Co., Ltd.; Qurient Co Ltd
- Tags: ctgov-sponsor; wave5-sponsor
- HQ: Seongnam
- Type: biotech

## Sources

- Wikidata Q30253835: https://www.wikidata.org/wiki/Q30253835
- ClinicalTrials.gov: trials led by Qurient Co., Ltd.: https://clinicaltrials.gov/search?lead=Qurient%20Co.%2C%20Ltd.

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- technologies: [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- targets: [AXL](https://onco.cc/targets/axl/), [CSF1R](https://onco.cc/targets/csf1r/)
- drugs: [Pembrolizumab](https://onco.cc/drugs/pembrolizumab/)
- trials: [Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors](https://onco.cc/trials/nct05394103/), [Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors](https://onco.cc/trials/nct05438420/)

---
JSON: https://onco.cc/api/v1/entities/qurient.json